A recent study has shown that the inhibition of RHOB by hsa-miR-3178 can increase the expression of ABC transporter proteins through the PI3K/Akt pathway, which finally leads to the resistance of pancreatic cancer to gemcitabine (92). The gene discussed is ABCG2; the disease is pancreatic neoplasm.